Disulfide cross-linked starch-based micelle as well as preparation method and application thereof
The formation of disulfide crosslinked starch-based micelles through the treatment of prolanase, periodate and cysteamine, solving the problems of hardening and uneven properties in starch-based micelles, and improving their in oral delivery The stability and bioavailability of the patient achieve targeted colon delivery.
Patent Information
- Application Number
- CN202410981408.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-19
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-19
AI Technical Summary
The existing methods for modifying starch-based micelles have problems with overhardening, uneven properties and biocompatibility, which limit their application in the field of oral delivery.
The glutinous corn starch was debranched by using prolanase, periodate oxidation to form dialdehyde dextrin, cysteamine grafting reaction and disulfide crosslinked starch-based micelles were formed through ultrasonic thiol oxidation, which increased its hydrophobicity and structural stability.
The water solubility and gastrointestinal stability of micelles are improved, the oral bioavailability of hydrophobic functional factors is enhanced, and the micelle size is controlled by controlling the amount of cysteamine added, achieving colonic targeted or oral delivery.
Smart Images

Figure CN118924683A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of nanomaterials, and specifically relates to a disulfide-crosslinked starch-based micelle and a preparation method and application thereof. Background Art
[0002] Many hydrophobic functional factors that are beneficial to human health are often limited in their oral absorption efficiency due to problems such as low water solubility, sensitivity to the environment (digestive enzymes, temperature, pH, etc.), difficulty in passing through the intestinal barrier, and easy interaction with food.
[0003] As a new encapsulation and delivery system for hydrophobic functional factors, micelles have attracted the attention of many researchers in recent decades. Micelles are nanocarriers with a core-shell structure composed of amphiphilic compounds. The internal hydrophobic core can encapsulate hydrophobic molecules, and the external hydrophilic shell is in contact with the water environment, which significantly improves the solubility of hydrophobic functional factors in water. Its tiny size, strong controllability, and high loading capacity can enhance the intestinal mucosal permeability of nanocarriers, achieve controllable release and targeted delivery in the gastrointestinal tract, and greatly improve the oral bioavailability of drugs. Compared with chemically synthesized materials, micelles of polysaccharide materials have the advantages of low toxicity, environmental friendliness, and biocompatibility, which is conducive to reducing potential adverse effects.
[0004] Starch is a polysaccharide widely found in nature, with the advantages of being cheap, easy to obtain, and highly safe. The rich hydroxyl structure of starch is an ideal group for chemical reactions. Other structures can be introduced through simple chemical modifications, thus giving starch new properties and functions. It is considered to be an ideal material for preparing micelles.
[0005] Modification methods for starch-based micelles have also been widely explored, such as using crosslinkers (epichlorohydrin or aldehyde compounds) to react with hydroxyl groups on starch molecules to form a crosslinked network; introducing inorganic acids or organic acids to convert hydroxyl groups into ester groups to change the hydrophilicity and hydrophobicity of starch; introducing acetylated groups to increase the hydrophobicity of starch, etc. These modification methods also have certain defects. For example, crosslinking may cause excessive hardening of starch granules, affecting their biodegradability; esterification reactions may be incomplete, resulting in uneven properties of starch micelles; acetylation will reduce the hydrophilicity of starch granules, affecting their application in water environments, and the introduction of acetyl groups will also affect the biocompatibility of starch. Therefore, it is necessary to find a new method for modifying starch-based micelles. Summary of the invention
[0006] The main purpose of the present invention is to provide a disulfide cross-linked starch-based micelle and a preparation method and application thereof, so as to overcome the shortcomings of the prior art.
[0007] In order to achieve the above-mentioned invention object, the technical solution adopted by the present invention includes:
[0008] The embodiment of the present invention provides a method for preparing disulfide cross-linked starch-based micelles, which comprises:
[0009] The waxy corn starch is debranched by pullulanase to obtain dextrin.
[0010] The dextrin is oxidized by using periodate to obtain dialdehyde dextrin;
[0011] Allowing cysteamine to undergo a grafting reaction with the dialdehyde dextrin to obtain cysteamine-dextrin;
[0012] Furthermore, the cysteamine-dextrin is dissolved in water and self-assembled to form micelles, and then ultrasonically thiol-oxidized to obtain disulfide-crosslinked starch-based micelles.
[0013] The embodiment of the present invention also provides disulfide cross-linked starch-based micelles prepared by the aforementioned preparation method.
[0014] The embodiment of the present invention also provides a method for preparing disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors, which comprises:
[0015] The disulfide-crosslinked starch-based micelles are prepared by the aforementioned preparation method;
[0016] And, the hydrophobic functional factor is mixed and homogeneously dispersed with the disulfide cross-linked starch-based micelles to obtain the disulfide cross-linked starch-based micelles loaded with the hydrophobic functional factor.
[0017] The embodiment of the present invention also provides disulfide cross-linked starch-based micelles loaded with hydrophobic functional factors obtained by the aforementioned preparation method.
[0018] The embodiments of the present invention also provide the use of the aforementioned disulfide-crosslinked starch-based micelles or disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors in the field of colon targeting or oral delivery.
[0019] Compared with the prior art, the present invention has the following beneficial effects:
[0020] (1) In the present invention, natural amino acid cysteamine is selected as a modifier. Cysteamine, due to its excellent biocompatibility, helps to reduce potential toxicity and side effects to the human body; at the same time, the free thiol group at the end of the cysteamine structure can easily form disulfide bonds between and within the molecules, which significantly enhances the structural stability of the micelles. In addition, cysteamine also has significant antioxidant properties, which can effectively protect the active ingredients in the micelles and prevent them from suffering from oxidative damage, thereby extending the shelf life of the active ingredients;
[0021] (2) The ultrasonic treatment used in the present invention can effectively disperse the agglomerated particles, reduce the size distribution range of the particles, and improve the uniformity of the particle size. At the same time, the ultrasonic wave can cause violent eddy currents and shearing in the liquid, increase the collision frequency of thiol groups between different chain segments, and accelerate the process of thiol oxidation to form disulfide bonds;
[0022] (3) The micelles in the present invention are mainly stabilized by disulfide bonds and hydrophobic interactions, supplemented by hydrogen bonds. The amount of cysteamine added can be controlled to change the content of free thiol groups, thereby controlling the size of the formed micelles. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are only some embodiments recorded in the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.
[0024] Figure 1 is a graph showing the change in particle size of starch-based micelles with pH in Examples 1-3 of the present invention and Comparative Example 1;
[0025] Figure 2 is a graph showing changes in potential of starch-based micelles with pH in Examples 1-3 of the present invention and Comparative Example 1;
[0026] Figure 3 is a graph showing the change in particle size of starch-based micelles with ionic strength in Examples 4-6 of the present invention and Comparative Example 2;
[0027] Figure 4 is a graph showing the change in potential of starch-based micelles with ionic strength in Examples 4-6 of the present invention and Comparative Example 2;
[0028] Figure 5a-Figure 5b The graph is a graph showing the cumulative release rate of curcumin over time of the starch-based micelles loaded with curcumin in Example 5 of the present invention and Comparative Example 2 at pH values of 1.2, 6.0, and 7.4, respectively. DETAILED DESCRIPTION
[0029] In view of the defects of the prior art, the inventors of this case have proposed the technical solution of the present invention after long-term research and extensive practice. By developing a new disulfide-crosslinked starch-based micelle to load the hydrophobic functional factor, not only the water solubility of the hydrophobic functional factor is improved, but also the stability in the gastrointestinal tract is enhanced. The reaction principle of the present invention is to reduce the molecular weight of starch molecules by enzymatic hydrolysis to form small molecular dextrins, making it easier to self-assemble, and then introduce cysteamine structure into the starch skeleton to improve the hydrophobicity of dextrin molecules. Aggregation occurs under hydrophobic interaction force to form micelles, and ultrasonic treatment is used to promote the oxidation of thiol groups to form disulfide-crosslinked starch-based micelles.
[0030] The technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0031] Specifically, as one aspect of the technical solution of the present invention, a method for preparing a disulfide-crosslinked starch-based micelle involves:
[0032] The waxy corn starch is debranched by pullulanase to obtain dextrin.
[0033] The dextrin is oxidized by using periodate to obtain dialdehyde dextrin;
[0034] Allowing cysteamine to undergo a grafting reaction with the dialdehyde dextrin to obtain cysteamine-dextrin;
[0035] Furthermore, the cysteamine-dextrin is dissolved in water and self-assembled to form micelles, and then ultrasonically thiol-oxidized to obtain disulfide-crosslinked starch-based micelles.
[0036] In some preferred embodiments, the preparation method specifically includes: mixing glutinous corn starch with a phosphate buffer solution with a pH value of 4.0 to 5.0 to form a glutinous corn starch dispersion, then heating it in a boiling water bath for gelatinization, then adding pullulanase and stirring the reaction in a water bath for 15 to 24 hours, then inactivating the enzyme and freeze-drying it to obtain dextrin.
[0037] Furthermore, the concentration of the waxy corn starch in the waxy corn starch dispersion is 3 to 6 w / v% (g / m1).
[0038] Furthermore, the usage ratio of the pullulanase to the waxy corn starch is 20-50 U:1 g.
[0039] In some preferred embodiments, the preparation method specifically includes: dissolving dextrin in water to form a dextrin solution, then adding periodate, mixing and stirring, and reacting at room temperature in the dark for 1 to 2 hours, then adding ethylene glycol to react for 1 to 2 hours, and then dialyzing and freeze-drying to obtain dialdehyde dextrin.
[0040] Furthermore, the concentration of dextrin in the dextrin solution is 2.5-5.0 w / v%.
[0041] Furthermore, the mass ratio of the periodate to dextrin is 10-40:100.
[0042] Further, the periodate includes sodium periodate and / or potassium periodate, but is not limited thereto.
[0043] In some preferred embodiments, the preparation method specifically includes: dissolving dialdehyde dextrin in water to form a dialdehyde dextrin solution, then adding MES hydrate and cysteamine, adjusting the pH value to 3-4 and stirring the reaction at room temperature for 3 hours, then adding sodium cyanoborohydride and stirring the reaction at room temperature for 72 hours, and then dialyzing and freeze-drying to obtain cysteamine-dextrin.
[0044] Furthermore, the concentration of dialdehyde dextrin in the dialdehyde dextrin solution is 1.0-2.5 w / v%.
[0045] Furthermore, the mass ratio of cysteamine to dialdehyde dextrin is 50:100.
[0046] Furthermore, the mass ratio of the sodium cyanoborohydride to the dialdehyde dextrin is 200-400:100.
[0047] In some preferred embodiments, the preparation method specifically includes: heating cysteamine-dextrin at 70-85°C for 10-30 minutes to dissolve water to form a cysteamine-dextrin solution, then shaking at room temperature for 12-24 hours to form a micelle solution, and then ultrasonicating at a power of 100-400W for 1-10 minutes to obtain disulfide-crosslinked starch-based micelles.
[0048] Furthermore, the concentration of cysteamine-dextrin in the cysteamine-dextrin solution is 0.5-2 w / v%.
[0049] Another aspect of the embodiments of the present invention further provides disulfide-crosslinked starch-based micelles prepared by the aforementioned preparation method.
[0050] Another aspect of the embodiments of the present invention further provides a method for preparing disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors, which comprises:
[0051] The disulfide-crosslinked starch-based micelles are prepared by the aforementioned preparation method;
[0052] And, the hydrophobic functional factor is mixed and homogeneously dispersed with the disulfide cross-linked starch-based micelles to obtain the disulfide cross-linked starch-based micelles loaded with the hydrophobic functional factor.
[0053] In some preferred embodiments, the preparation method specifically includes: adding the hydrophobic functional factor to the disulfide-crosslinked starch-based micelles and homogenizing at 8000-12000 rpm for 1N2 min, then shaking at room temperature for 12-24 h, and then centrifuging to remove unencapsulated hydrophobic functional factors to obtain disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors.
[0054] Furthermore, the mass volume ratio of the hydrophobic functional factor to the disulfide cross-linked starch-based micelles is 20-50 mg:100 ml.
[0055] Furthermore, the hydrophobic functional factor includes any one or more combinations of curcumin, quercetin, and catechol, but is not limited thereto.
[0056] In some more specific embodiments, the method for preparing the disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors comprises the following steps:
[0057] (1) using pullulanase to debranch glutinous corn starch to obtain dextrin;
[0058] (2) oxidizing the dextrin with sodium periodate to obtain dialdehyde dextrin;
[0059] (3) grafting cysteamine onto the dialdehyde dextrin according to a reductive amination reaction to obtain cysteamine-dextrin;
[0060] (4) heating the cysteamine-dextrin to dissolve in water, and then shaking at room temperature to allow the hydrophobic segments to aggregate with each other under the driving force of interaction, and finally self-assemble to form micelles. Then, ultrasonic treatment is performed to promote sulfhydryl oxidation to obtain disulfide-crosslinked starch-based micelles;
[0061] (5) adding the hydrophobic functional factor to the micelle solution, homogenously dispersing it, and shaking it at room temperature to allow the hydrophobic functional factor to migrate to the hydrophobic core of the micelle, thereby obtaining disulfide-crosslinked starch-based micelles loaded with the hydrophobic functional factor.
[0062] Furthermore, step (1) specifically comprises: using a phosphate buffer solution with a pH value of 4.0 to 5.0 to prepare a starch milk with a concentration of 3 to 6 w / v%, heating in a boiling water bath for 30 to 60 minutes for gelatinization, adding pullulanase (the ratio of pullulanase to glutinous corn starch is 20 to 50 U: 1 g) after cooling, stirring in a water bath for 15 to 24 hours, heating at 85 to 95° C. for 10 to 20 minutes after the reaction is completed to inactivate the enzyme, and freeze-drying to obtain dextrin powder;
[0063] Furthermore, step (2) specifically comprises: preparing a dextrin solution with a concentration of 2.5-5.0 w / v%, adding sodium periodate (the mass ratio of sodium periodate to dextrin is 10-40:100), mixing and stirring, reacting at room temperature in the dark for 1-2 hours, adding 0.5-1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1-2 hours to remove unreacted sodium periodate, then dialyzing with distilled water (dialysis bag molecular weight cutoff 1000-3500 Da) for three days, and freeze-drying to obtain dialdehyde dextrin powder;
[0064] Furthermore, step (3) specifically comprises: preparing a dialdehyde dextrin solution with a concentration of 1.0-2.5 w / v%, adding MES hydrate and cysteamine (the mass ratio of cysteamine to dialdehyde dextrin is 50:100) with a final concentration of 0.1 M, adjusting the pH value to 3-4 with hydrochloric acid, and stirring at room temperature for 3 hours. Then, sodium cyanoborohydride (the mass ratio of sodium cyanoborohydride to dialdehyde dextrin is 200-400:100) is added, and stirred at room temperature for 72 hours. After the reaction is completed, dialyzing with distilled water at pH=3 (dialysis bag molecular weight cutoff 1000-3500Da) for three days, and freeze-drying to obtain cysteamine-dextrin powder;
[0065] Furthermore, step (4) specifically comprises: preparing a cysteamine-dextrin solution with a concentration of 0.5-2 w / v%, heating at 70-85° C. for 10-30 min to dissolve, and shaking at room temperature for 12-24 h to obtain a micelle solution. Subsequently, ultrasonicating at a power of 100-400 W for 1-10 min to obtain a disulfide-crosslinked starch-based micelle solution;
[0066] Furthermore, step (5) specifically comprises: adding curcumin to the disulfide cross-linked starch-based micelle solution (the mass volume ratio of curcumin to the disulfide cross-linked starch-based micelle is 20-50 mg: 100 mL), homogenizing at a speed of 8000-12000 revolutions per minute for 1-2 minutes, then shaking at room temperature for 12-24 hours to allow the curcumin to migrate into the hydrophobic core of the micelle, and then centrifuging to remove the unencapsulated curcumin to obtain a micelle solution loaded with curcumin.
[0067] Another aspect of the embodiments of the present invention further provides disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors obtained by the aforementioned preparation method.
[0068] Another aspect of the embodiments of the present invention further provides the use of the aforementioned disulfide-crosslinked starch-based micelles or disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors in the field of colon targeting or oral delivery.
[0069] The technical solution of the present invention is further described in detail below in conjunction with several preferred embodiments and drawings. This embodiment is implemented on the premise of the technical solution of the invention, and a detailed implementation method and specific operation process are given, but the protection scope of the present invention is not limited to the following embodiments.
[0070] Unless otherwise specified, the experimental materials used in the following examples can be purchased from conventional biochemical reagent companies.
[0071] Example 1
[0072] 1. Preparation of Dextrin
[0073] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0074] 2. Preparation of dialdehyde dextrin
[0075] Prepare a dextrin solution with a concentration of 3.0 w / v%, add sodium periodate (the mass ratio of sodium periodate to dextrin is 20:100), mix and stir, react for 2 hours at room temperature in the dark, add 1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1 hour to remove unreacted sodium periodate, then dialyze with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dry to obtain dialdehyde dextrin powder;
[0076] 3. Preparation of Cysteamine-dextrin
[0077] Prepare a dialdehyde dextrin solution with a concentration of 1.0 w / v%, add MES hydrate and cysteamine (the mass ratio of cysteamine to dialdehyde dextrin is 25:100) with a final concentration of 0.1 M, adjust the pH value to 3 with hydrochloric acid, and stir at room temperature for 3 hours. Then add sodium cyanoborohydride (the mass ratio of sodium cyanoborohydride to dialdehyde dextrin is 400:100), stir at room temperature for 72 hours, dialyze with distilled water at pH = 3 (dialysis bag molecular weight cutoff 1000Da) for three days after the reaction is completed, and freeze-dry to obtain cysteamine-dextrin powder;
[0078] 4. Preparation of disulfide cross-linked starch-based micelles
[0079] A 1.0 w / v% cysteamine-dextrin solution was prepared, heated at 85° C. for 10 min to dissolve, and shaken at room temperature for 24 h to obtain a micelle solution, which was then ultrasonicated at 300 W for 3 min to obtain a disulfide-crosslinked starch-based micelle solution.
[0080] Example 2
[0081] 1. Preparation of Dextrin
[0082] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0083] 2. Preparation of dialdehyde dextrin
[0084] Prepare a dextrin solution with a concentration of 3.0 w / v%, add sodium periodate (the mass ratio of sodium periodate to dextrin is 20:100), mix and stir, react for 2 hours at room temperature in the dark, add 1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1 hour to remove unreacted sodium periodate, then dialyze with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dry to obtain dialdehyde dextrin powder;
[0085] 3. Preparation of Cysteamine-dextrin
[0086] Prepare a dialdehyde dextrin solution with a concentration of 1.0w / v%, add MES hydrate and cysteamine (the mass ratio of cysteamine to dialdehyde dextrin is 50:100) with a final concentration of 0.1M, adjust the pH value to 3 with hydrochloric acid, and stir at room temperature for 3 hours. Then add sodium cyanoborohydride (the mass ratio of sodium cyanoborohydride to dialdehyde dextrin is 400:100), stir at room temperature for 72 hours, dialyze with distilled water at pH=3 (dialysis bag molecular weight cutoff 1000Da) for three days after the reaction is completed, and freeze-dry to obtain cysteamine-dextrin powder;
[0087] 4. Preparation of disulfide cross-linked starch-based micelles
[0088] A 1.0 w / v% cysteamine-dextrin solution was prepared, heated at 85° C. for 10 min to dissolve, and shaken at room temperature for 24 h to obtain a micelle solution, which was then ultrasonicated at 300 W for 3 min to obtain a disulfide-crosslinked starch-based micelle solution.
[0089] Example 3
[0090] 1. Preparation of Dextrin
[0091] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0092] 2. Preparation of dialdehyde dextrin
[0093] Prepare a dextrin solution with a concentration of 3.0 w / v%, add sodium periodate (the mass ratio of sodium periodate to dextrin is 20:100), mix and stir, react for 2 hours at room temperature in the dark, add 1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1 hour to remove unreacted sodium periodate, then dialyze with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dry to obtain dialdehyde dextrin powder;
[0094] 3. Preparation of Cysteamine-dextrin
[0095] Prepare a dialdehyde dextrin solution with a concentration of 1.0 w / v%, add MES hydrate and cysteamine (the mass ratio of cysteamine to dialdehyde dextrin is 100:100) with a final concentration of 0.1 M, adjust the pH value to 3 with hydrochloric acid, and stir at room temperature for 3 hours. Then add sodium cyanoborohydride (the mass ratio of sodium cyanoborohydride to dialdehyde dextrin is 400:100), stir at room temperature for 72 hours, dialyze with distilled water at pH = 3 (dialysis bag molecular weight cutoff 1000Da) for three days after the reaction is completed, and freeze-dry to obtain cysteamine-dextrin powder;
[0096] 4. Preparation of disulfide cross-linked starch-based micelles
[0097] A 1.0 w / v% cysteamine-dextrin solution was prepared, heated at 85° C. for 10 min to dissolve, and shaken at room temperature for 24 h to obtain a micelle solution, which was then ultrasonicated at 300 W for 3 min to obtain a disulfide-crosslinked starch-based micelle solution.
[0098] Example 4
[0099] 1. Preparation of Dextrin
[0100] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0101] 2. Preparation of dialdehyde dextrin
[0102] A dextrin solution with a concentration of 3.0 w / v% was prepared, sodium periodate (the mass ratio of sodium periodate to dextrin was 20:100) was added, mixed and stirred, reacted for 2 h at room temperature in the dark, 1 mL / g (dextrin dry basis mass) of ethylene glycol was added and reacted for 1 h to remove unreacted sodium periodate, then dialyzed with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dried to obtain dialdehyde dextrin powder;
[0103] 3. Preparation of Cysteamine-dextrin
[0104] Prepare a dialdehyde dextrin solution with a concentration of 1.0 w / v%, add MES hydrate and cysteamine (the mass ratio of cysteamine to dialdehyde dextrin is 25:100) with a final concentration of 0.1 M, adjust the pH value to 3 with hydrochloric acid, and stir at room temperature for 3 hours. Then add sodium cyanoborohydride (the mass ratio of sodium cyanoborohydride to dialdehyde dextrin is 400:100), stir at room temperature for 72 hours, dialyze with distilled water at pH = 3 (dialysis bag molecular weight cutoff 1000Da) for three days after the reaction is completed, and freeze-dry to obtain cysteamine-dextrin powder;
[0105] 4. Preparation of disulfide cross-linked starch-based micelles
[0106] A 1.0 w / v% cysteamine-dextrin solution was prepared, heated at 85° C. for 10 min to dissolve, and shaken at room temperature for 24 h to obtain a micelle solution, which was then ultrasonicated at 300 W for 3 min to obtain a disulfide-crosslinked starch-based micelle solution.
[0107] 5. Preparation of disulfide cross-linked starch-based micelles loaded with curcumin
[0108] Curcumin was added to the disulfide-crosslinked starch-based micelle solution (the mass volume ratio of curcumin to disulfide-crosslinked starch-based micelle was 50 mg: 100 mL), homogenized at 12,000 rpm for 1 to 2 min, then shaken at room temperature for 24 h to allow curcumin to migrate into the hydrophobic core of the micelles, and then centrifuged to remove the unencapsulated curcumin to obtain a micelle solution loaded with curcumin.
[0109] Example 5
[0110] 1. Preparation of Dextrin
[0111] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0112] 2. Preparation of dialdehyde dextrin
[0113] Prepare a dextrin solution with a concentration of 3.0 w / v%, add sodium periodate (the mass ratio of sodium periodate to dextrin is 20:100), mix and stir, react for 2 hours at room temperature in the dark, add 1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1 hour to remove unreacted sodium periodate, then dialyze with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dry to obtain dialdehyde dextrin powder;
[0114] 3. Preparation of Cysteamine-dextrin
[0115] Prepare a dialdehyde dextrin solution with a concentration of 1.0w / v%, add MES hydrate and cysteamine (the mass ratio of cysteamine to dialdehyde dextrin is 50:100) with a final concentration of 0.1M, adjust the pH value to 3 with hydrochloric acid, and stir at room temperature for 3 hours. Then add sodium cyanoborohydride (the mass ratio of sodium cyanoborohydride to dialdehyde dextrin is 400:100), stir at room temperature for 72 hours, dialyze with distilled water at pH=3 (dialysis bag molecular weight cutoff 1000Da) for three days after the reaction is completed, and freeze-dry to obtain cysteamine-dextrin powder;
[0116] 4. Preparation of disulfide cross-linked starch-based micelles
[0117] A 1.0 w / v% cysteamine-dextrin solution was prepared, heated at 85° C. for 10 min to dissolve, and shaken at room temperature for 24 h to obtain a micelle solution, which was then ultrasonicated at 300 W for 3 min to obtain a disulfide-crosslinked starch-based micelle solution.
[0118] 5. Preparation of disulfide cross-linked starch-based micelles loaded with curcumin
[0119] Curcumin was added to the disulfide-crosslinked starch-based micelle solution (the mass volume ratio of curcumin to disulfide-crosslinked starch-based micelle was 50 mg: 100 mL), homogenized at 12,000 rpm for 1 to 2 min, then shaken at room temperature for 24 h to allow curcumin to migrate into the hydrophobic core of the micelles, and then centrifuged to remove the unencapsulated curcumin to obtain a micelle solution loaded with curcumin.
[0120] Example 6
[0121] 1. Preparation of Dextrin
[0122] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0123] 2. Preparation of dialdehyde dextrin
[0124] Prepare a dextrin solution with a concentration of 3.0 w / v%, add sodium periodate (the mass ratio of sodium periodate to dextrin is 20:100), mix and stir, react for 2 hours at room temperature in the dark, add 1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1 hour to remove unreacted sodium periodate, then dialyze with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dry to obtain dialdehyde dextrin powder;
[0125] 3. Preparation of Cysteamine-dextrin
[0126] Prepare a dialdehyde dextrin solution with a concentration of 1.0 w / v%, add MES hydrate and cysteamine (the mass ratio of cysteamine to dialdehyde dextrin is 100:100) with a final concentration of 0.1 M, adjust the pH value to 3 with hydrochloric acid, and stir at room temperature for 3 hours. Then add sodium cyanoborohydride (the mass ratio of sodium cyanoborohydride to dialdehyde dextrin is 400:100), stir at room temperature for 72 hours, dialyze with distilled water at pH = 3 (dialysis bag molecular weight cutoff 1000Da) for three days after the reaction is completed, and freeze-dry to obtain cysteamine-dextrin powder;
[0127] 4. Preparation of disulfide cross-linked starch-based micelles
[0128] A 1.0 w / v% cysteamine-dextrin solution was prepared, heated at 85° C. for 10 min to dissolve, and shaken at room temperature for 24 h to obtain a micelle solution, which was then ultrasonicated at 300 W for 3 min to obtain a disulfide-crosslinked starch-based micelle solution.
[0129] 5. Preparation of disulfide cross-linked starch-based micelles loaded with curcumin
[0130] Curcumin was added to the disulfide-crosslinked starch-based micelle solution (the mass volume ratio of curcumin to disulfide-crosslinked starch-based micelle was 50 mg: 100 mL), homogenized at 12,000 rpm for 1 to 2 min, then shaken at room temperature for 24 h to allow curcumin to migrate into the hydrophobic core of the micelles, and then centrifuged to remove the unencapsulated curcumin to obtain a micelle solution loaded with curcumin.
[0131] Comparative Example 1
[0132] 1. Preparation of Dextrin
[0133] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0134] 2. Preparation of dialdehyde dextrin
[0135] Prepare a dextrin solution with a concentration of 3.0 w / v%, add sodium periodate (the mass ratio of sodium periodate to dextrin is 20:100), mix and stir, react for 2 hours at room temperature in the dark, add 1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1 hour to remove unreacted sodium periodate, then dialyze with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dry to obtain dialdehyde dextrin powder;
[0136] 3. Preparation of dialdehyde dextrin micelles
[0137] A dialdehyde dextrin solution with a concentration of 1.0 w / v% was prepared, heated at 85°C for 10 minutes to dissolve, and shaken at room temperature for 24 hours to obtain a micelle solution, which was then ultrasonicated at a power of 300 W for 3 minutes to obtain a dialdehyde dextrin micelle solution.
[0138] Comparative Example 2
[0139] 1. Preparation of Dextrin
[0140] A starch milk with a concentration of 6 w / v% was prepared using a phosphate buffer solution with a pH value of 4.5, and heated in a boiling water bath for 30 minutes for gelatinization. After cooling, pullulanase (the ratio of pullulanase to waxy corn starch was 20 U: 1 g) was added, and stirred in a water bath for 24 hours. After the reaction was completed, the enzyme was inactivated by heating at 95°C for 20 minutes, and dextrin powder was obtained by freeze drying.
[0141] 2. Preparation of dialdehyde dextrin
[0142] Prepare a dextrin solution with a concentration of 3.0 w / v%, add sodium periodate (the mass ratio of sodium periodate to dextrin is 20:100), mix and stir, react for 2 hours at room temperature in the dark, add 1 mL / g (dextrin dry basis mass) of ethylene glycol to react for 1 hour to remove unreacted sodium periodate, then dialyze with distilled water (dialysis bag molecular weight cutoff 1000 Da) for three days, and freeze-dry to obtain dialdehyde dextrin powder;
[0143] 3. Preparation of dialdehyde dextrin micelles
[0144] A dialdehyde dextrin solution with a concentration of 1.0 w / v% was prepared, heated at 85°C for 10 minutes to dissolve, and shaken at room temperature for 24 hours to obtain a micelle solution, which was then ultrasonicated at a power of 300 W for 3 minutes to obtain a dialdehyde dextrin micelle solution.
[0145] 4. Preparation of curcumin-loaded dialdehyde dextrin micelles
[0146] Curcumin was added to the dialdehyde dextrin micelle solution (the mass volume ratio of curcumin to dialdehyde dextrin micelle was 50 mg: 100 mL), homogenized at 12,000 rpm for 1 to 2 min, and then shaken at room temperature for 24 h to allow curcumin to migrate into the hydrophobic core of the micelles. The unencapsulated curcumin was then removed by centrifugation to obtain a micelle solution loaded with curcumin.
[0147] Comparative Example 3
[0148] The method is the same as that of Example 2, except that the ultrasonic treatment process in step 4 is missing.
[0149] Comparative Example 4
[0150] The method is the same as that of Example 5, except that the ultrasonic treatment time in step 4 is 30 min.
[0151] In order to further illustrate the technical effects of the present invention, measurements were performed on the relevant products obtained in Examples 1-6 and Comparative Examples 1-4.
[0152] 1. Determination of free thiol content and disulfide bond content of prepared disulfide cross-linked starch-based micelles
[0153] The free thiol and disulfide bond contents were determined by Ellman's reagent and sodium borohydride reduction methods.
[0154] (1) Cysteamine-dextrin micelles (5.00 mg / mL, w / v, 0.2 mL) were mixed with phosphate buffer (0.5 M, pH 8.0, 1.8 mL) and DTNB (2 mL, 0.03%, w / v, dissolved in phosphate buffer (0.5 M, pH 8.0)). After the reaction, the mixture was stored in a dark place for 2 h, and the absorbance of the sample at a wavelength of 412 nm was measured. The free thiol concentration was calculated according to the Lambert-Beer law. The formula is as follows:
[0155] Free thiol content (μmol / g) = 73.53 × A 512 ×D / C
[0156] 73.53 is 106 / (1.36×10 4 ),1.36×10 4 is the molar absorbance, 10 6 is the conversion factor, A 412 is the absorbance of the supernatant at 412 nm, D is the dilution factor, and C is the sample concentration (mg / mL).
[0157] (2) The polymer dispersion was reduced with sodium borohydride (NaBH4) to convert disulfide bonds into free thiols, thereby determining the disulfide bond content. Cysteamine-dextrin micelles (5.00 mg / mL, w / v, 0.2 mL) were mixed with phosphate buffer (0.05 M, pH 6.8, 1.3 mL), and freshly prepared NaBH4 (4%, w / v, 2 mL) was added and reacted at 37°C for 1 h to reduce. The mixture was neutralized with phosphate buffer solution (1 M, pH 8.5, 2 mL). Finally, the disulfide bond content was calculated according to the above determination method.
[0158] 2. The loading amount of curcumin in micelles was determined by UV-visible spectrophotometry
[0159] The absorbance of the cysteamine-dextrin micelles loaded with curcumin was measured at 422 nm using a UV-visible spectrophotometer. The concentration of Cur was calculated based on the standard curve. The loading amount of Cur encapsulated in the micelles was then calculated based on the formula.
[0160] Loading amount (%) = mass of encapsulated curcumin / mass of micelle carrier × 100%
[0161] 4. The particle size and zeta potential of disulfide-cross-linked starch-based micelles with different free thiol contents were determined using a zeta potential analyzer, and the pH stability and ionic strength stability of the micelles were evaluated.
[0162] 5. The in vitro release behavior of curcumin in Example 5 was determined by dialysis
[0163] The simulated gastrointestinal release medium is: a hydrochloric acid solution with a pH of 1.2 (simulated gastric pH), a PBS with a pH of 7.4 (simulated small intestinal pH), and a PBS with a pH of 6.0 (simulated colon pH). Due to the low water solubility of curcumin, 1% (v / v) Tween 80 is added to the release medium. A cysteamine-dextrin micellar solution (10 mL) is placed in a dialysis bag (molecular weight cutoff 3500 Da) and immersed in a release medium (50 mL). At regular intervals, the release medium (2 mL) is taken out and replaced with an equal volume of fresh phosphate buffer. The cumulative release of curcumin is calculated by ultraviolet spectrophotometry according to the curcumin standard curve.
[0164] Table 1 Free thiol and disulfide bond contents of starch-based micelles in Examples 1-3 and Comparative Examples 1, 3, and 4
[0165]
[0166] As can be seen from Table 1, the free thiol and disulfide bond contents of the disulfide cross-linked starch-based micelles of Examples 1-3 gradually increase, while the dialdehyde dextrin micelles of Comparative Example 1 do not contain free thiol. The free thiol and disulfide bond contents of Examples 2 and 3 vary slightly, indicating that when a certain amount of cysteamine is added, the reaction reaches saturation. As can be seen from Example 2, Comparative Example 3 and Comparative Example 4, ultrasonic treatment can promote the conversion of free thiol groups to disulfide bonds.
[0167] Table 2 Loading amount of curcumin-loaded starch-based micelles in Examples 4-6 and Comparative Example 2
[0168] name Example 4 Example 5 Example 6 Comparative Example 2 Loading capacity (%) 0.286±0.005 0.463±0.001 0.501±0.005 0.039±0.001
[0169] As can be seen from Table 2, the curcumin loading of the dialdehyde dextrin micelles of Comparative Example 2 is only 0.039%, while the curcumin loading of the disulfide cross-linked starch-based micelles of Examples 4-6 is 0.286%, 0.463%, and 0.501%, respectively, which is increased by 7.33-12.85 times. This is because the increase in the number of hydrophobic disulfide bonds promotes the hydrophobic interaction between the micelles and curcumin, thereby increasing the loading amount.
[0170] Table 3 Particle size and zeta potential of micelles of Examples 1-6 and Comparative Examples 1-4
[0171] name Size(nm) Zeta potential(mV) Example 1 92.52±1.90 23.58±0.89 Example 2 120.12±3.60 29.70±1.29 Example 3 157.12±3.68 29.90±2.16 Example 4 168.72±2.26 21.97±0.72 Example 5 143.60±2.85 26.25±0.77 Example 6 141.00±1.25 26.75±1.06 Comparative Example 1 152.67±3.39 -1.84±0.15 Comparative Example 2 209.87±5.44 -11.90±0.62 Comparative Example 3 189.45±6.25 25.63±0.22 Comparative Example 4 204.22±1.49 22.14±1.09
[0172] As shown in Table 3, compared with Comparative Examples 1 and 2, Examples 1-6 have smaller particle sizes and higher zeta potential values, indicating that the stability of disulfide-crosslinked starch-based micelles is stronger. As the number of free thiol groups increases, the particle size of Examples 1-3 shows an increasing trend. This is because as the free thiol content increases, the probability of collision between hydrophobic segments to form disulfide bonds increases, resulting in the formation of larger micelles by connection polymerization. The increase in particle size of Examples 4-6 after loading curcumin is because the hydrophobic curcumin occupies the hydrophobic core of the micelle, resulting in an increase in volume. The particle size of Comparative Examples 3 and 4 is significantly larger than that of Examples 2 and 5, which shows that the ultrasonic treatment department breaks up larger micelle aggregates into smaller micelles through the cavitation effect.
[0173] from Figure 1 and Figure 2 It can be seen that as the pH value increases, the particle size of Examples 1-3 and the comparative example increases first and then decreases. This is because the decrease in the zeta potential value reduces the electrostatic repulsion between micelles and increases particle aggregation. The reduction in particle size after the pH reaches 7.4 is due to the charge screening effect of the counterions, which leads to a decrease in particle size.
[0174] from Figure 3 and Figure 4 It can be seen that, except for Example 1, the other samples all showed good stability at salt ion concentrations below 200 mM, and their particle sizes increased with increasing salt ion concentrations, while the absolute value of zeta potential gradually decreased with increasing salt ion concentrations. The increase in particle size is attributed to the shielding of the surface charge of the micelles by salt ions and the reduction of electrostatic repulsion between particles.
[0175] from Figure 5a-Figure 5b It can be seen that at pH 1.2, the cumulative release rate of curcumin in Example 5 is low, with only 17.21% released in 2 hours. This is because the micelles have a higher surface potential under acidic conditions, and the system is stable under strong electrostatic repulsion. At pH 6.0 and pH 7.4, the total release of curcumin in Example 5 was 42.57% and 26.63%, respectively, showing colon-targeted release. In contrast, Comparative Example 2 showed very high curcumin release under different pH conditions, indicating that its release characteristics are not suitable for gastrointestinal delivery.
[0176] In summary, the disulfide-crosslinked starch-based micelles obtained by the above-mentioned technical scheme of the present invention use natural amino acid-cysteamine as a modifier, and self-assembled micelles with good performance can be obtained by heating for dissolution, room temperature oscillation, and ultrasonic treatment, and the method is simple, efficient, and safe. The size of the prepared products is nanoscale, which can be used to encapsulate hydrophobic functional factors such as curcumin, quercetin, catechol, etc., which greatly improves their water solubility. The micelles also have good anti-environmental stress stability such as pH and ionic strength stability. In vitro model release shows that the disulfide-crosslinked starch-based micelles loaded with curcumin can well prevent the drug from leaking prematurely in the stomach, and can be efficiently delivered to the small intestine and colon to achieve efficient delivery. The prepared products are expected to be widely used in the fields of oral delivery, controlled release, and maintenance of biological activity of nutrients.
[0177] In addition, the inventors of this case also referred to the aforementioned embodiments and conducted experiments with other raw materials, process operations, and process conditions described in this specification, and obtained relatively ideal results.
[0178] It should be understood that the technical solution of the present invention is not limited to the above-mentioned specific implementation cases. Any technical deformation made according to the technical solution of the present invention without departing from the scope of protection of the purpose of the present invention and the claims shall fall within the protection scope of the present invention.
Claims
1. A method for preparing disulfide cross-linked starch-based micelles, characterized in that: include: The waxy corn starch is debranched by pullulanase to obtain dextrin. The dextrin is oxidized by using periodate to obtain dialdehyde dextrin; Allowing cysteamine to undergo a grafting reaction with the dialdehyde dextrin to obtain cysteamine-dextrin; Furthermore, the cysteamine-dextrin is dissolved in water and self-assembled to form micelles, and then ultrasonically thiol-oxidized to obtain disulfide-crosslinked starch-based micelles.
2. The preparation method according to claim 1, characterized in that: Specifically include: The waxy corn starch is mixed with a phosphate buffer solution having a pH value of 4.0 to 5.0 to form a waxy corn starch dispersion, and then heated in a boiling water bath for gelatinization, and then pullulanase is added and stirred in a water bath for reaction for 15 to 24 hours, and then the enzyme is inactivated and freeze-dried to obtain dextrin; Preferably, the concentration of the waxy corn starch in the waxy corn starch dispersion is 3 to 6 w / v%; Preferably, the usage ratio of the pullulanase to the waxy corn starch is 20-50 U:1 g.
3. The preparation method according to claim 1, characterized in that: Specifically include: Dissolve dextrin in water to form a dextrin solution, then add periodate, mix and stir, and react at room temperature in the dark for 1 to 2 hours, then add ethylene glycol to react for 1 to 2 hours, and then dialyze and freeze-dry to obtain dialdehyde dextrin; Preferably, the concentration of dextrin in the dextrin solution is 2.5-5.0 w / v%; Preferably, the mass ratio of the periodate to dextrin is 10-40:
100. Preferably, the periodate comprises sodium periodate and / or potassium periodate.
4. The preparation method according to claim 1, characterized in that: Specifically include: Dissolve dialdehyde dextrin in water to form a dialdehyde dextrin solution, then add MES hydrate and cysteamine, adjust the pH value to 3-4, stir and react at room temperature for 3 hours, then add sodium cyanoborohydride and stir and react at room temperature for 72 hours, then dialyze and freeze-dry to obtain cysteamine-dextrin; Preferably, the concentration of dialdehyde dextrin in the dialdehyde dextrin solution is 1.0 to 2.5 w / v%; Preferably, the mass ratio of cysteamine to dialdehyde dextrin is 50:100; Preferably, the mass ratio of the sodium cyanoborohydride to the dialdehyde dextrin is 200-400:
100.
5. The preparation method according to claim 1, characterized in that: Specifically include: The cysteamine-dextrin is heated at 70-85° C. for 10-30 minutes to dissolve water to form a cysteamine-dextrin solution, and then shaken at room temperature for 12-24 hours to form a micelle solution, and then ultrasonicated at a power of 100-400 W for 1-10 minutes to obtain disulfide-crosslinked starch-based micelles; Preferably, the concentration of cysteamine-dextrin in the cysteamine-dextrin solution is 0.5-2 w / v%.
6. Disulfide cross-linked starch-based micelles prepared by the preparation method according to any one of claims 1 to 5.
7. A method for preparing disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors, characterized in that: include: The disulfide-crosslinked starch-based micelles are prepared by the preparation method described in any one of claims 1 to 5; And, the hydrophobic functional factor is mixed and homogeneously dispersed with the disulfide cross-linked starch-based micelles to obtain the disulfide cross-linked starch-based micelles loaded with the hydrophobic functional factor.
8. The preparation method according to claim 7, characterized in that: Specifically include: Adding the hydrophobic functional factor to the disulfide-crosslinked starch-based micelles and homogenizing at 8000-12000 rpm for 1-2 minutes, then shaking at room temperature for 12-24 hours, and then centrifuging to remove the unencapsulated hydrophobic functional factor to obtain disulfide-crosslinked starch-based micelles loaded with the hydrophobic functional factor; Preferably, the mass volume ratio of the hydrophobic functional factor to the disulfide cross-linked starch-based micelle is 20-50 mg:100 ml; Preferably, the hydrophobic functional factor includes any one or more combinations of curcumin, quercetin and catechol.
9. Disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors prepared by the preparation method according to claim 7 or 8.
10. Use of the disulfide-crosslinked starch-based micelles according to claim 6 or the disulfide-crosslinked starch-based micelles loaded with hydrophobic functional factors according to claim 9 in the field of colon targeting or oral delivery.
Citation Information
Patent Citations
Cross-linked starch-based polymers for drug-delivery
CN112334493A
Preparation method and application of acetylated starch nano-micelle
CN113150312A
Starch-based dual-load functional nanoparticles as well as preparation method and application thereof
CN113575951A
RS3 type resistant starch-based colon-targeted delivery carrier as well as preparation method and application thereof
CN115501189A
Solubilization and targeted delivery of drugs with self-assembling amphiphilic polymers
SG168586A1
